An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis ELEVATE UC OLE: An Open-Label Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Arena Pharmaceuticals, Inc.
Start Date
October 7, 2020
End Date
September 30, 2024
Administered By
Medicine, Gastroenterology
Awarded By
Arena Pharmaceuticals, Inc.
Start Date
October 7, 2020
End Date
September 30, 2024